Q4 2022
Released Mar 1, 2023, after the close
10-K filed Mar 1, 2023, 60 days after period end · 0001628280-23-005832
Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$62.04M$62.04M derived+41.1% vs Q4 2021+8.9% vs Q3 2022
Net Income-$61.77M-$61.77M derivedN/M vs Q4 2021N/M vs Q3 2022
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$97,294,000N/M
Operating Cash Flowderived-$109,292,000N/M
Free Cash Flowderived-$113,705,000N/M
Margins · derived
Operating margin-156.8%+341.8 pt vs Q4 2021
Net margin-99.6%+382.2 pt vs Q4 2021
What the release said
The release
Same quarter
| Metric | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $62.04M | $43.96M | $15.09M | $4.65M |
| Net Income | -$61.77M | -$211.83M | -$76.55M | -$46.43M |
| EPS Diluted | — | -$2.22 | -$0.88 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR